BriaCell Announces Positive Phase IIa Proof of Concept Data in Advanced Breast Cancer; Initiates Combination Study

BriaCell has achieved positive proof of concept in the Phase IIa study of Bria-IMT in advanced breast cancer patients Data shows promising anti-tumor activity of Bria-IMT in heavily pre-treated advanced breast cancer patients Impressive Phase IIa efficacy data is similar or superior to those of other approved breast cancer drugs of similar clinical-stage of development […]